Objectives: To assess the impact of an infection team review of patients receiving antibiotics in six hospitals across the UK and to establish the suitability of these patients for continued care in the community.
Introduction
Management of infections within the hospital setting represents a significant burden to the UK National Health Service (NHS). 1 The current emphasis on cost control and managed care has created an impetus to discharge patients as soon as possible or avoid hospital admission altogether for therapeutic interventions that have traditionally been delivered in hospitals. 2, 3 The input of infection specialists in the assessment of severity of infection and the management of antibiotics is important for the quality of care as well as cost containment. 4 For patients treated within the hospital setting, once the acute infection has been controlled with intravenous (iv) or oral antibiotics, it is possible for patients to be discharged back to the community with continued antibiotic therapy, providing there is some support or monitoring in the community, over and above that which would usually be expected in primary care. 5 Some hospitals offer outpatient parenteral antibiotic therapy (OPAT) outside the hospital setting, and standards for OPAT have been developed, 6 -10 and it is likely that a proportion of patients can be switched from iv to oral treatment and can continue their treatment by this route in the community. 5 Early discharge of suitable patients with appropriate support would free beds and secondary care NHS resources. This would improve capacity, reduce cost, improve patient choice and satisfaction, potentially reduce healthcare-associated infections (HCAIs) and other complications and allow resources to be re-allocated to increase patient throughput and decrease waiting times. Above all, being discharged from hospital and receiving care at home would appear to be what most patients want, according to the National Concern for Healthcare Infections. 11 An evaluation tool was developed to assist ward-based infection teams with antibiotic management and stewardship, but also to assist assessment for early discharge. Early discharge criteria were developed ( Figure 1 ) by a working party of physicians, surgeons, antimicrobial pharmacists and a patient representative. In a series of meetings, a structured discussion technique (Delphi method) was used to establish the agreed criteria. These criteria were included in the evaluation tool, a short forma that allows details of antibiotic use, infection management and discharge planning to be recorded.
The primary objective was to assess patients being treated for infection with antibiotics in hospital, and to judge whether they were receiving the most appropriate antibiotic, at the right dose and the most appropriate route and whether they were suitable for completing their treatment out of hospital. In addition, the potential bed-day savings that might be realized if the patient completed his/her antibiotic treatment out of hospital was estimated, and a financial analysis is reported in a companion paper. 12 
Methods
The evaluations were carried out prospectively by infection teams on daily routine ward rounds in six hospital Trusts across the UK in 2010. The individual hospitals were not comparable, as they varied in size, specialties and function and included a mix of acute hospitals, general hospitals, teaching and specialist tertiary referral centres. The infection teams were not uniform either, but this variation reflects the nature of clinical infection teams in routine practice across the UK. At a minimum they consisted of a physician trained in antibiotic management (infectious diseases or microbiologist) and an antibiotic pharmacist. The evaluation tool was the same across the sites.
Data were collected prospectively on acute medical and surgical wards during routine ward rounds. Antibiotic management decisions were made at that time and either acted on immediately by the infection team or communicated immediately to the regular medical team. Antibiotic changes included stopping antibiotics and switching from iv to oral administration ( Figure 1 ). Any change in antibiotic use was documented in the patient notes with a request for the regular team to contact the infection team if there were any concerns or patient deterioration. A clinical decision based on the early discharge criteria (Figure 1 ) was made at the same time as to whether the patient needed to continue antibiotic therapy in hospital or outside. However, this decision was purely academic to determine a potential early discharge date if the resources for outpatient management had been available. The aim was to establish which patients with infection might be suitable for early discharge if there was suitable enhanced care and monitoring available in the community. The methods and results of an economic assessment are reported in a companion paper. 12 Each patient's suitability for discharge was formally assessed by using the evaluation tool with agreed criteria for suitability/unsuitability for discharge.
The criteria assessed for suitability for discharge were infection clinically stable or improving, resolution of fever and haemodynamically stable, improving inflammatory markers [white blood cell (WBC) count and C-reactive protein (CRP)], no complex infection requiring continued hospital care and the absence of any other major factor preventing discharge (co-morbidity, requirement for significant further medical or surgical input requiring major rehabilitation or social services input, patient Dryden et al.
or health team choice). All these criteria needed to be met to be suitable for early discharge ( Figure 1 ). In addition, for oral therapy, the patient needed to be able to take fluids and food by mouth. All patients judged to be suitable for discharge on the day of review were followed up to find the actual date of discharge. The difference in days was the bed-days that could have been saved if the patient had been discharged on the day of review. All data were recorded anonymously on a data collection form. Patients were identified by a unique number on the data collection form, which was linked to their hospital number and data via a log that remained on the hospital premises. After collection, anonymized data were entered into a study database for data cleaning and analysis, and preparation of a report of results for each hospital.
Results
In the six hospitals a total of 1356 patients were reviewed, of whom 429 (32%) were receiving antibiotics. Of these patients, 165 (38%) were on iv+oral antibiotics and 264 (62%) were on oral antibiotics alone. The range of antimicrobial agents used was extensive (Table 1) . Ninety-nine (23%) patients on antibiotics Infection team impact on antibiotic management (including 26 on iv treatment) had their antibiotics stopped immediately on clinical grounds ( Figure 2 ). The clinical indications for antibiotic treatment as well as suitability or otherwise for early discharge are illustrated in Figure 3 . Three-hundred-and-thirty (77%) patients needed to continue antibiotics. Thirty-four per cent (47/139) of those on iv antibiotics were switched to oral treatment. In the follow-up with the regular clinical teams, no adverse effects as a result of altering antibiotic prescriptions were noted. One-fifth (89/429) of all patients on antibiotics were recommended for discharge on the basis of having met the improvement criteria in the evaluation tool and on the basis of clinical assessment during the review.
Patients suitable for OPAT
Of the 89 patients who were suitable for discharge, 55 were suitable for oral outpatient treatment, 24 had their antibiotics stopped and 10 (from five of the six hospitals) would have required OPAT. The focus of infection in these patients were prosthetic joint (4), intra-abdominal (2), vascular graft (1), endocarditis (1) and respiratory tract (2).
Assessment of patients for discharge
On the basis of the discharge criteria, 89 (21%) patients on antibiotics were considered suitable for immediate discharge on the day of review by the infection teams in the six hospitals. All of these patients would have required additional monitoring and care by a hospital team after discharge rather than discharge to the care of their general practitioner (GP). This accounted for almost 20% of patients on iv+oral antibiotics and 20% of those on oral antibiotics alone. Although this study did not specifically address the level of enhanced monitoring and care required, it is likely that for most patients this would have included regular clinical review of the focus of infection, Figure 2 . Summary of early discharge and antibiotic management data.
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monitoring vital observations and ensuring antibiotic administration and compliance until such time as the care of the patient could be transferred to the GP.
Reasons preventing patient discharge
The evaluation tool asked whether the patient could be discharged that day with enhanced care in the community. The 89 patients described above were suitable, with the remainder being unsuitable. The main reason for the latter was that the patients required continued surgical and or medical input. Co-morbidities, rehabilitation and social service requirements were other reasons preventing discharge (Figure 4 ).
Potential bed-days saved
Of the 89 patients considered suitable for discharge by the infection teams on the days of review, an actual discharge date was available for 73 patients during the study period. If these 73 patients had been discharged at the time of the review, 483 bed-days could have been saved.
Discussion
This evaluation described the clinical impact of a formal antibiotic review by teams of infection specialists in six hospitals. Significant changes in the duration of antibiotic use and route of administration were achieved, resulting in a considerable reduction in antibiotic usage. Although formal clinical outcome was not measured in this study, follow-up with the regular clinical teams did not reveal any detrimental consequences of antibiotic alteration. The economic impact is reported in a companion paper. 12 In contrast to other such reviews of antibiotic use, this evaluation also assessed the potential for early discharge in these patients.
Resistance to currently available antimicrobials is a global public health threat. Resistance is closely associated with the selective pressure of antibiotics, and therefore the volume of antibiotic use. 13, 14 One strategy for countering the threat of resistance is to reduce the volume of antibiotic use without detriment to patients. In hospitals this can be achieved by recommendations, guidelines and care bundles, 15 -17 or by regular reviews of antibiotic use by an antimicrobial management team or infection specialists. 18 -20 Antibiotic choices can be influenced in a cost-effective fashion by an infection team without sacrificing patient safety. In one study, 50% of patients initially treated with expensive parenteral antibiotics had their regimens refined after 3 days of therapy, and these modifications resulted in good clinical outcomes with a substantial reduction in antibiotic expense. 21 In another study, the intervention of an antimicrobial management team resulted in a reduction in patient charges by slightly more than $4000 and hospital costs by $2000. 22 In this study, we have demonstrated for the first time in the UK that infection team intervention results in a reduction in the use of iv antibiotics, earlier iv/oral switch and shorter duration of antibiotic therapy, although clinical outcomes were not formally measured. Along with the potential for early discharge in some of these patients, the infection team intervention led to significant economic advantages. 12 Criteria have already been developed to improve the monitoring of inpatient antibiotic prescribing, 7, 15 and many of these recommendations have been incorporated into quality improvement programmes such as the UK Department of Health and European Union antibiotic prescribing bundles. 16, 17 Nevertheless, it is clear from routine practice that these recommendations are not always followed in an effective way because this evaluation has clearly demonstrated that intervention by an infection team made a substantial difference in the duration of therapy and iv/oral switch, despite such recommendations being included in hospital policies. This study suggests that there is still much potential for improvement in inpatient antibiotic management, and if guidelines and bundles do not provide clear enough directions, then this may be best achieved by the regular input of an infection team. There is precedence for this. Where the advice of infection teams is not followed, the clinical outcome is worse. 23 Infection consultations for patients with staphylococcal bacteraemia resulted in improved treatment, the removal of infected foci, the detection of complications and better outcomes. 15 -17 Furthermore, there is evidence that in the absence of infection specialist input, there is poor assessment of the severity of infection, resulting in over-treatment of less severe infection and under-treatment of severe infection. 4, 24 Infection team evaluation therefore has the potential to improve the quality of antibiotic prescribing, optimize the treatment of infections, contain the costs associated with antibiotic use and bed-days and reduce antibiotic-associated collateral damage. There is thus a compelling argument for infection teams to be resourced to manage all antibiotic use, although clearly this would have huge logistical implications.
It can be argued that this study had limitations due to the lack of uniformity between the six sites. The data from each evaluation were applicable only to the local hospital involved, as the hospitals differed in size, specialties and function. Although inclusion criteria were acute medical or surgical cases, the wards and patient groups selected were not uniform, and the infection teams carrying out the review and assessment of patients were made up of different people at each hospital. The number of patients reviewed per hospital was also not proportional to the total bed complement. However, the lack of uniformity between the sites and the teams demonstrated that the evaluation tool can be effectively used in a variety of clinical settings. The antibiotic review and patient assessment for discharge and outpatient antibiotic treatment were done using a systematic approach and with agreed criteria. Data were collected using consistent methodology. The rounds were educational and contributed directly to patient management. The evaluation was applicable and reproducible in any hospital as part of a formal antibiotic review and early discharge programme. The study was multicentred and involved hospitals of very different size, specialties and function.
Optimal antibiotic management should now be obligatory in all healthcare institutions, 16, 17 and toolkits exist to support antibiotic stewardship.
7 Table 1 shows the range of antibiotics used in the patients prior to the intervention. The choice of agents reflects some adherence to the currently fashionable UK national advice to avoid the four 'C' antibiotics, thought to be at higher risk of promoting Clostridium difficile colitis. The use of cephalosporins, ciprofloxacin (quinolones) and clindamycin were low, in keeping with the recommendations. In contrast, however, co-amoxiclav was the most commonly used agent.
Antibiotic resistance is directly related to the volume of antibiotic use. 13, 14 Hence, reducing the volume of total antibiotic use may be an important intervention for reducing levels of resistance. 25 This review resulted in almost a quarter of patients having their antibiotics stopped immediately. This in itself is interesting, and is an important benefit even without any cost savings related to early discharge. It shows that the resourcing of an infection team (consisting of at least an infection medical specialist with an antibiotic pharmacist), and giving the team the authority to alter antibiotic prescribing, can result in a reduction in the volume of antibiotic use, increased iv to oral switch and probably improved de-escalation from broadspectrum to narrower spectrum antibiotic prescribing. If carried out on a wide scale, this would have significant cost advantages, but probably more importantly it will reduce the selective pressure of antibiotics on microorganisms. This could be an important factor in controlling antibiotic resistance in units where multidrug resistance is high. 26, 27 More than one-third of all patients were on iv+oral antibiotics, and on review the infection teams considered that 15% no longer required their antibiotic therapy and could stop immediately. More than one-third of the remaining patients on iv antibiotics had a clinical need to continue antibiotic therapy but no longer required the iv route for antibiotic administration and could be switched to an appropriate oral formulation. While the iv route has benefits and is necessary in specific clinical situations, it is associated with higher risks, costs and staff time than the oral route. This result suggests there is a need for educating staff on the differences, benefits and risks between oral and iv administration, and when and how to choose the iv route appropriately. Reducing or avoiding unnecessary use of iv therapy would reduce the costs associated with drugs, equipment and staff time, and improve the quality of patient care and productivity on the ward. In addition, a reduction in peripheral line days would reduce the risk of vascular line-associated infection and bacteraemia, which is an increasingly important consideration for all UK hospitals.
Ten patients on iv therapy were judged to be suitable for early discharge and therefore suitable for OPAT. In this evaluation there was a role for OPAT, but the numbers were low. This study demonstrated that an OPAT service is a useful asset for antibiotic management in secondary care, but the majority of patients on antibiotics can be switched to oral treatment on discharge.
Often the decision and responsibility to discontinue or change iv to oral antibiotics is left to a more senior member of the medical or surgical staff who may be available to review patients less frequently than needed for optimum efficiency in antibiotic management. Antibiotic rounds with an infection team can be used as a bedside educational tool for medical staff, encouraging multidisciplinary interaction between clinical teams and ultimately resulting in positive feedback for ward staff in antibiotic management and stewardship.
There is little facility in the UK for regular monitoring of convalescent patients in the community. Care is either in the hospital or there has to be a transfer of clinical responsibility to Dryden et al. primary care. Many patients remain in the hospital for supervised monitoring and antibiotic administration, and there is a need for a middle way for patients whose clinical signs are resolving. This study has demonstrated that there is a significant group of patients that would benefit from such an approach.
A major finding of the evaluation was that at the time of review, 21% of patients fulfilled the criteria for early discharge and could have continued their treatment in the community. Once patients with acute infection are stabilized, much of their continuing care involves monitoring, drug administration and supportive treatment such as wound care. Delivering this at home would be preferable to most patients. 6, 10, 11 To achieve this in practice, a mechanism for community support and monitoring needs to be in place. This community service could take the form of domiciliary visits, return to the outpatient clinic or telephone calls. The service would have to represent a level of care somewhere between the hospital and the GP. One model of delivery for this would be a 'virtual ward', whereby the patient would remain registered with the hospital, but would be accommodated at home or in a nursing home and their care would be monitored by a nursing team for the virtual ward. 28 To our knowledge, such a system does not exist yet in the UK for the management of infection, but has the potential for enhancing the patient's experience and recovery, as well as reducing costs and HCAIs.
Most patients do not want to stay in hospital longer than is necessary. A patient group-National Concern for Healthcare Infection-has listed many patient benefits for care outside the hospital environment. 11 Other studies have listed advantages and disadvantages for early discharge over hospital stay 6, 8 and these are fairly consistent and agree with what the patients themselves want ( Table 2) .
The main reason preventing discharge of the remaining 79% of patients was that they had a need for further medical or surgical input, rehabilitation, co-morbidities and social services needs. All of these were beyond the control of the infection team. Each of these reasons merits further investigation to identify appropriate strategies to resolve the issues in each case. Increasing the frequency and availability of specialist medical and surgical review and the accessibility and timeliness of rehabilitation and social services might have an additional considerable impact on patient flow through secondary care.
Early discharge review showed a potential savings of 483 bed-days that could have been realized from continuing infection treatment in the community. This was just from a snapshot review on a specific day in each hospital. If such a review programme was introduced into routine care throughout hospitals, the bed-days saved and economic gain over time would be even more marked. Full details of an economic analysis undertaken alongside this study are reported in a companion paper. 12 One other study has shown marked economic gains from early iv/oral switch and discharge from hospital in patients with resistant Gram-positive infections. 5 The results of this evaluation clearly indicate that a more structured approach to antibiotic management can result in improved antibiotic stewardship, a reduction in volume of antibiotic use and more rapid iv/oral switch. Introduction of this approach into clinical practice in a routine way would be educational as well as improving the quality of antibiotic use in hospitals. It is likely that the development of community care teams to monitor patients with infection out of hospital could reduce the length of hospital stay. A more detailed cost analysis on the antibiotic management and early discharge data from this study accompanies this paper. 12 
Funding
Data were generated by the authors within their routine work. Authors were not funded for data collection. An unrestricted educational grant from Pfizer supported the meetings of the authors to develop the standards and discuss the progress of the work. Pfizer funded pH Associates to assist with data management. 
Transparency declarations

